Influence of Nutrition on Nasal and Bronchial Affliction in Patients With Allergy on Grass-Pollen
NCT00519740 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2009-02-04
Summary
The study is meant to observe the influence of nutrition on nasal and bronchial discomfort in patients with allergy on grass pollen after specific bronchial provocation. Therefore, the investigators will record the patients' nutrition habits and measure the blood level of long chained polyunsaturated fatty-acids.
Conditions
- Bronchial Hyperreactivity
- Hypersensitivity
- Allergy
- Bronchial Asthma
Interventions
- OTHER
-
inhalative specific bronchial provocation with grass-pollen
Sponsors & Collaborators
-
Johann Wolfgang Goethe University Hospital
lead OTHER
Principal Investigators
-
Stefan Zielen, M.D., Ph.D. · Goethe University, Department of Pulmonology
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-08-31
- Primary Completion
- 2008-08-31
- Completion
- 2008-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Effects of Sublingual Immunotherapy on Grasspollen Allergy
NCT00150514 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation
NCT00623701 ·Status: COMPLETED ·Phase: PHASE3
-
Resolution of Allergic Inflammation
NCT01992835 ·Status: COMPLETED ·Phase: NA
-
Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber
NCT03496103 ·Status: COMPLETED ·Phase: PHASE1
-
Revaccination With Pollinex® Quattro
NCT02579720 ·Status: COMPLETED
-
Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge
NCT01657097 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen
NCT00241410 ·Status: COMPLETED ·Phase: PHASE1
-
International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis
NCT02041624 ·Status: TERMINATED
-
A Pilot Monocenter Study to Assess Cellular and Soluble Biomarkers in Nasal Secretions
NCT00297843 ·Status: COMPLETED
-
The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure Unit
NCT00209365 ·Status: COMPLETED ·Phase: NA
-
Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2)
NCT01953471 ·Status: COMPLETED
-
Early Intervention in Allergic Patients
NCT05040828 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture
NCT00264459 ·Status: COMPLETED ·Phase: PHASE3
-
Nut Allergy Study: Double-blind Challenge and Oral Desensitization
NCT01502878 ·Status: COMPLETED ·Phase: NA
-
A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis
NCT00812799 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis
NCT00550875 ·Status: COMPLETED ·Phase: PHASE2
-
Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen
NCT00104377 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Nasal Inflammatory Biomarkers
NCT03450031 ·Status: COMPLETED ·Phase: NA
-
Documentation of Efficacy of Intralymphatic Allergen Immunotherapy
NCT05191186 ·Status: COMPLETED ·Phase: PHASE3
-
Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients
NCT00857779 ·Status: COMPLETED ·Phase: PHASE2
-
Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract
NCT05297760 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of the Nasal Gel "Nascum®-Plus" on Allergic Symptoms
NCT03772405 ·Status: COMPLETED ·Phase: NA
-
Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels
NCT04389034 ·Status: COMPLETED
-
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
NCT01240889 ·Status: COMPLETED ·Phase: NA
-
Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide
NCT00312312 ·Status: UNKNOWN ·Phase: NA